Patents by Inventor Bruce Carleton

Bruce Carleton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPOUND-INDUCED OTOTOXICITY
    Publication number: 20140147516
    Abstract: Methods of determining a subject's ototoxicity risk from administration of a pharmacotherapeutic compound having an ototoxicity risk, methods of administering a pharmacotherapeutic compound having an ototoxicity risk and oligonucleotides, peptide nucleic acids, arrays, and addressable collections for performing embodiments of the methods are provided herein.
    Type: Application
    Filed: December 3, 2013
    Publication date: May 29, 2014
    Applicant: The University of British Columbia
    Inventors: Michael R. Hayden, Bruce Carleton, Colin Ross
  • POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPLEX INDUCED OTOTOXICITY
    Publication number: 20140023726
    Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of ototoxicity in response to receiving one or more platinum-coordinating compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of ototoxicity.
    Type: Application
    Filed: September 24, 2013
    Publication date: January 23, 2014
    Applicant: The University of British Columbia
    Inventors: Michael Hayden, Bruce Carleton, Colin Ross
  • POLYMORPHISMS PREDICTIVE OF ANTHRACYCLINE- INDUCED CARDIOTOXICITY
    Publication number: 20130344170
    Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of cardiotoxicity in response to receiving one or more anthracycline compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of cardiotoxicity.
    Type: Application
    Filed: September 3, 2013
    Publication date: December 26, 2013
    Applicant: THE UNIVERSITY OF BRITISH COLUMBIA
    Inventors: Michael Hayden, Bruce Carleton, Colin Ross
  • POLYMORPHISMS PREDICTIVE OF ANTHRACYCLINE- INDUCED CARDIOTOXICITY
    Publication number: 20110312907
    Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of cardiotoxicity in response to receiving one or more anthracycline compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of cardiotoxicity.
    Type: Application
    Filed: November 15, 2007
    Publication date: December 22, 2011
    Inventors: Michael Hayden, Bruce Carleton, Colin Ross
  • POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPOUND-INDUCED OTOTOXICITY
    Publication number: 20110104257
    Abstract: Methods of determining a subjects ototoxicity risk from administration of platinum-coordinating compounds having an ototoxicity risk, methods of administering a platinum-coordinating compound having an ototoxicity risk and oligonucleotides, peptide nucleic acids, arrays and addressable collections for performing embodiments of the methods are provided herein.
    Type: Application
    Filed: April 14, 2009
    Publication date: May 5, 2011
    Inventors: Michael R. Hayden, Bruce Carleton, Colin Ross
  • POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPLEX INDUCED OTOTOXICITY
    Publication number: 20100062079
    Abstract: Provided are methods, nucleic acids, and arrays for assessing the susceptibility of a subject to the development of ototoxicity in response to receiving one or more platinum-coordinating compounds, the method including determining the presence or absence of one or more polymorphisms, wherein the presence or absence of one or more such polymorphisms is indicative of susceptibility to the development of ototoxicity.
    Type: Application
    Filed: November 15, 2007
    Publication date: March 11, 2010
    Inventors: Michael Hayden, Bruce Carleton, Colin Ross